Dr. Abhisek Mitra   is a research fellow in M.D. Anderson Cancer Center, Houston, TX, USA. His current research projects highlight a biologically occurring cytokine interleukin-30 (IL30) and its anti-inflammatory role. His work was the first to show that the IL30 regulates resident liver NKT cells to alleviate liver fibrosis. He also had the extensive experience with liver inflammation, cancer stem cells and dynamics of resident liver immune cells. He did his Ph.D. from the University of Texas in the field of T cells signaling where he discovered a novel serine site (S193) in STAT5 that undergoes constitutive phosphorylation in hematological malignancies. He currently serves in the editorial board of MOJ Immunology, Asian Journal of Medical Sciences, Bioaccent and Journal of Cancer Prevention & Current Research. Dr. Abhisek Mitra   is a research fellow in M.D. Anderson Cancer Center, Houston, TX, USA. His current research projects highlight a biologically occurring cytokine interleukin-30 (IL30) and its anti-inflammatory role. His work was the first to show that the IL30 regulates resident liver NKT cells to alleviate liver fibrosis. He also had the extensive experience with liver inflammation, cancer stem cells and dynamics of resident liver immune cells. He did his Ph.D. from the University of Texas in the field of T cells signaling where he discovered a novel serine site (S193) in STAT5 that undergoes constitutive phosphorylation in hematological malignancies. He currently serves in the editorial board of MOJ Immunology, Asian Journal of Medical Sciences, Bioaccent and Journal of Cancer Prevention & Current Research.

Dr. Abhisek Mitra's research interests include immunology, inflammation, NKT cells, cancer stem cells and cell signaling.